CHIR Chiron (MM)

Chiron to Present at Morgan Stanley Global Healthcare Unplugged Conference EMERYVILLE, Calif., April 28 /PRNewswire-FirstCall/ -- Chiron Corporation today announced that it will present at the Morgan Stanley 2nd Annual Global Healthcare Unplugged Conference in Miami on Wednesday, May 5, at 9:30 a.m. EDT. Investors may access a live webcast of the presentation at http://www.chiron.com/webcast. In order to register and download any necessary software, please log on 15 minutes early. About Chiron Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide. The company's consistent success comes from its pioneering science, skill in delivering innovations in biotechnology and disciplined business approach. Chiron believes that science has the power to improve people's lives and harnesses that power to transform public health. This year, Chiron Vaccines celebrates 100 years of advancing medicine with the anniversary of two founding companies. In 1904, Emil von Behring and Achille Sclavo independently started companies in Germany and Italy, respectively, dedicated to the research, development and manufacture of vaccines to protect humanity from infectious disease. As the fifth-largest vaccine manufacturer in the world, Chiron remains dedicated to the legacies of von Behring and Sclavo to prevent disease and develop new vaccines to improve human health globally. DATASOURCE: Chiron Corporation CONTACT: Chiron Corporate Communications & Investor Relations, media, +1-510-923-6500, or investors, +1-510-923-2300 Web site: http://www.chiron.com/

Copyright